Pharma Stability: Insights, Guidelines, and Expertise
Regulatory agencies like the USFDA, EMA, and CDSCO increasingly demand a systematic, risk-based approach to drug development. Submissions that include QbD-driven stability studies demonstrate:
Click to read the full article.
At the heart of QbD is a clear connection between the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), and associated risk assessments. Documentation should include:
Click to read the full article.
The QTPP defines the intended quality attributes of a pharmaceutical product, including safety, efficacy, and shelf life. When applying QbD to stability studies, QTPP elements such as:
Click to read the full article.
Stability protocols designed without QbD logic often fail to justify storage conditions, bracketing strategies, or shelf-life projections. Training helps scientists:
Click to read the full article.
Traditional stability sampling plans often rely on fixed intervals and volumes, ignoring specific product risk profiles. QbD changes this by requiring a rationale tied to:
Click to read the full article.
According to ICH Q8, prior knowledge refers to publicly available information, internal legacy data, and platform experience relevant to the product or process. In stability testing, this includes:
Click to read the full article.
Conventional stability protocols are often rigid, following ICH guidelines by default without product-specific customization. Key characteristics include:
Click to read the full article.
Change control refers to the structured process of evaluating, approving, implementing, and documenting any alteration to a validated process, method, or document. In stability testing, changes may include:
Click to read the full article.
The QTPP outlines the critical characteristics that a product must meet to ensure desired quality, safety, and efficacy. For stability scientists, the QTPP defines parameters such as:
Click to read the full article.
The Quality Target Product Profile (QTPP) is the cornerstone of QbD. For smaller companies, this doesn’t have to be a 100-page document. A one-page QTPP that outlines dosage form, route, strength, shelf life, storage condition, and intended use is sufficient to guide development.
Click to read the full article.